Oral corticosteroid for inflammatory and autoimmune conditions — reliable control with a favourable steroid profile.
Defzalix‑6 contains Deflazacort 6mg, an oral corticosteroid derived from prednisolone. It is valued for a comparatively favourable profile on bone mineral density and glucose metabolism relative to equivalent doses of some other steroids.
| Brand name | Defzalix‑6 |
|---|---|
| Composition | Deflazacort 6mg |
| Dosage form | Tablet |
| Pack size | 10 × 10 Tablets |
| Therapeutic category | Pain & Ortho |
| Schedule | Prescription only (Rx) |
| Marketed by | Neolix Pharma Pvt Ltd, Bangalore, India |
Defzalix‑6 is manufactured and marketed by Neolix Pharma Pvt Ltd. For product availability, stockist and distribution enquiries, quality documentation or partnership opportunities, write to admin@neolixpharma.com or use the enquiry form on our homepage.
